Related Experiment Video
Updated: May 28, 2025

Early Viral Entry Assays for the Identification and Evaluation of Antiviral Compounds
Published on: October 29, 2015
Cyclin Dependent Kinases in Antiviral Drug Discovery
Olga Tarasova1, Walter Filgueira de Azevedo Junior2
1Department of Bioinformatics, Institute of Biomedical Chemistry, 10-7, Pogodinskaya st., Moscow, 119121, Russia.
Abstract:
Cyclin-dependent kinases that are responsible for cell cycle control, have been studied for over 30 years as therapeutic targets for the treatment of cancer and inflammation. In the past twenty years, their activities in various viral infections have been investigated in the search of novel therapeutic strategies in the treatment of viral infections. The interest in evaluating antiviral activity of cyclin-dependent kinase inhibitors is closely linked to their role as host factors in viral replication. Due to the development of viral resistance, the strategies directed toward the targeting host machinery are still under investigation. This review is dedicated to the analysis of the molecular mechanisms of viral infection control by cyclin-dependent kinases that may reveal the potential mechanisms of action for their inhibitors and regulators as antiviral agents. We also consider recent efforts and achievements in the development of potential antiviral agents based on the cyclin-dependent kinase inhibitors and regulators, including their effects on various viruses, side effects, and toxicities.
Insights
Cyclin-dependent kinases (CDKs) are key regulators of the cell cycle and are being explored as targets for antiviral therapies. Inhibitors of these kinases show promise in combating viral infections by targeting host replication factors.
Area of Science:
- Molecular Biology
- Virology
- Pharmacology
Background:
- Cyclin-dependent kinases (CDKs) regulate the cell cycle and are established therapeutic targets for cancer and inflammation.
- Their role in viral replication has led to investigations into CDK inhibitors as novel antiviral strategies.
- Targeting host factors is crucial due to increasing viral resistance to conventional treatments.
Purpose of the Study:
- To analyze the molecular mechanisms of viral infection controlled by CDKs.
- To explore the potential of CDK inhibitors and regulators as antiviral agents.
- To review recent advancements in developing CDK-based antivirals, including their efficacy, side effects, and toxicities.
Main Methods:
- Literature review focusing on the interplay between CDKs and viral replication.
- Analysis of molecular mechanisms underlying CDK involvement in various viral infections.
- Compilation and assessment of data on existing and emerging CDK inhibitors as antiviral agents.
Main Results:
- CDKs play a significant role as host factors in the replication of various viruses.
- CDK inhibitors demonstrate potential antiviral activity by disrupting viral replication cycles.
- Research is ongoing to optimize these inhibitors for efficacy and safety against diverse viral pathogens.
Conclusions:
- CDK inhibitors represent a promising class of antiviral agents by targeting essential host machinery.
- Understanding CDK-viral interactions is key to developing effective strategies against drug-resistant viruses.
- Further research is needed to fully elucidate the therapeutic potential and mitigate the toxicities of CDK-based antivirals.
Related Concept Videos
Inhibition of Cdk Activity
M-Cdk Drives Transition Into Mitosis
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Retrovirus Life Cycles
Positive Regulator Molecules
Drug Discovery: Overview
Anaphase Promoting Complex

